Thursday, May 23, 2013

• Vical Appoints Richard M. Beleson and Stephen A. Sherwin, M.D., to Board of DirectorsGlobeNewswire (Thu, May 23)
• VICAL INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Thu, May 23)

Monday, May 20, 2013

• Interesting VICL Put And Call For Julyat TheStreet (Mon, May 20)

Friday, May 17, 2013

• VICAL INC FinancialsEDGAR Online Financials (Fri, May 17)
• Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharmaat TheStreet (Fri, May 17)

Tuesday, May 14, 2013

• Vical's CEO Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha (Tue, May 14)

Friday, May 10, 2013

• Short Interest In Vical Moves 21.2% Higherat TheStreet (Fri, May 10)
• VICAL INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, May 10)

Thursday, May 9, 2013

• Vical's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha (Thu, May 9)
• Vical Earnings: Here’s Why Investors are Happy Nowat Wall St. Cheat Sheet (Thu, May 9)
• Q1 2013 Vical Inc. Earnings Release - Before Market OpenCCBN (Thu, May 9)
• Vical Reports First Quarter 2013 Financial Results and Progress in Key Development ProgramsGlobeNewswire (Thu, May 9)

Wednesday, May 8, 2013

• VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Wed, May 8)

Tuesday, May 7, 2013

• Galena: Improving Cancer Vaccines for the Futureat Motley Fool (Tue, May 7)
• Vical to Present at May Investor ConferencesGlobeNewswire (Tue, May 7)

Monday, May 6, 2013

• Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza VaccinesGlobeNewswire (Mon, May 6)

Friday, May 3, 2013

• Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trialat Seeking Alpha (Fri, May 3)

Thursday, May 2, 2013

• Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial ResultsGlobeNewswire (Thu, May 2)

Wednesday, May 1, 2013

• Biotech Stock Value Fundamentally Based on Individual Drug Development and the Competing Landscape: Expert Analyst Boris Peaker Discusses His Coverage of the Biotechnology Sector with The Wall Street TranscriptWall Street Transcript (Wed, May 1)

Monday, April 29, 2013

• A Tale Of Three Pharmaceuticals: Getting Exciting In 2013at Seeking Alpha (Mon, Apr 29)

Add VICL News to My Yahoo!